Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000155

Director sold 3,080 shares at an average $22.14 ($68,204)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
SATO VICKI L Director 2024-07-01 Sale 10b5-1 −2,980 $22.12 $65,918 119,356 D
SATO VICKI L Director 2024-07-01 Sale 10b5-1 −100 $22.86 $2,286 119,256 D
Open-market sales · 3,080 sh · avg $22.14 · $68,204
Loading xslF345X05/wk-form4_1720055578.xml…